MedTrace Logo

Prognostic Value Of Short-Term Follow-up Biomarkers After Discharge In hOspitalized Patients With Acute Heart Failure

NCT04437628 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2024-09-19

No results posted yet for this study

Summary

Several surrogate biomarkers including natriuretic peptide(NP), and growth differentiation factor-15(GDF-15) and ST2 has prognostic significance in heart failure(HF), and reductions in its value may predict clinical improvement. However, there are limited data regarding the prognostic value of these biomarkers during short-term follow-up after discharge in acute decompensated heart failure. The purpose of this study is to evaluate the prognostic value of short-term follow-up surrogate biomarkers for predicting prognosis of hospitalized patients with acute decompensated heart failure.

Conditions

Sponsors & Collaborators

  • Roche diagnostics Korea

    collaborator UNKNOWN

  • Wonju Severance Christian Hospital

    lead OTHER

Principal Investigators

  • Byung-Su Yoo, MD, PhD · Wonju College of Medicine, Yonsei University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2024-12-31
Completion
2025-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04437628 on ClinicalTrials.gov